Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Clinical trials sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd., explained in plain language.
-
New drug aims to cut ventilator time for sepsis lung patients
Disease control Recruiting nowThis study tests an experimental drug called YD0743 in adults with sepsis who have developed severe lung failure (ARDS) and need a breathing machine. The main goal is to see if the drug helps patients spend fewer days on the ventilator compared to a placebo. About 309 ICU patient…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated Jun 01, 2026 18:08 UTC
-
New pill aims to ease pain after belly surgery
Symptom relief Recruiting nowThis study tests an experimental painkiller called HL-1186 for people with moderate to severe pain after abdominal surgery. About 40 adults will receive either the drug or a placebo to see if it safely reduces pain over 48 hours. The goal is to find better ways to manage post-sur…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 03, 2026 12:05 UTC
-
New pill aims to ease post-surgery pain without opioids
Symptom relief Recruiting nowThis study tests an experimental tablet called HL-1186 for people with moderate to severe pain after surgery. About 72 adults having certain types of surgery will receive either the drug or a placebo. The goal is to see if the drug safely reduces pain over 48 hours.
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 02, 2026 11:40 UTC
-
New pill could offer relief for chronic sinusitis sufferers
Symptom relief Recruiting nowThis study tests a new tablet called HTMC0658 for people with chronic sinusitis who do not have nasal polyps. The goal is to see if it can improve sinus symptoms and reduce inflammation seen on CT scans. About 30 adults aged 18 to 75 will take part. The study is in Phase 2a, mean…
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated May 29, 2026 14:16 UTC